Narmada Gelatines logo

Narmada Gelatines

NARMADAGELATINESLTD NSE

Key Fundamentals

MicrocapSpecialty ChemicalsChemicals
Market Cap
₹283 Cr
Volatility
Moderate
P/E Ratio
8.2
EBITDA
₹41.60 Cr
Return on Equity
21.68%
Debt to Equity
0.06
Book Value
₹240.09
EPS
₹23.8
52W High
₹545
52W Low
₹327.3

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

4
  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 38.6% CAGR over last 5 years
  • Company has been maintaining a healthy dividend payout of 32.0%

Weaknesses

1
  • The company has delivered a poor sales growth of 9.82% over past five years.

Growth Rate

Revenue Growth
13.17% higher than 3Y
Net Income Growth
75% higher than 3Y
Cash Flow Change
52.74% lower than 3Y
ROE
44.63%
ROCE
43.19%
EBITDA Margin (Avg.)
40.12%

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
43.66
41.59
47.08
49.47
43.22
47.91
48.02
49.77
45.77
51.21
56.73
61.7
56.37
Expenses
37.57
37.71
42.38
42.85
37.93
42.68
41.44
42.29
38.25
41.86
46.06
47.94
44.65
Operating Profit
6.09
3.88
4.7
6.62
5.29
5.23
6.58
7.48
7.52
9.35
10.67
13.76
11.72
OPM %
13.95%
9.33%
9.98%
13.38%
12.24%
10.92%
13.7%
15.03%
16.43%
18.26%
18.81%
22.3%
20.79%
Other Income
0.27
0.39
0.45
0.5
0.56
0.77
0.29
0.03
0.04
0.55
0.05
0.14
0.14
Interest
0.09
0.09
0.05
0.03
0.03
0.27
0.55
0.36
0.24
0.2
0.29
0.29
0.15
Depreciation
0.5
0.51
0.51
0.52
0.52
0.59
0.56
0.55
0.65
0.65
0.65
0.92
0.76
PBT
5.77
3.67
4.59
6.57
5.3
5.14
5.76
6.6
6.67
9.05
9.78
12.69
10.95
Tax %
24.78%
27.25%
25.49%
25.27%
24.53%
25.49%
25.69%
18.79%
25.34%
28.4%
24.34%
24.51%
25.21%
Net Profit
4.34
2.67
3.42
4.91
4
3.83
4.28
5.36
4.98
6.48
7.4
9.58
8.19
EPS in Rs
7.17
4.41
5.65
8.12
6.61
6.33
7.07
8.86
8.23
10.71
12.23
15.84
13.54
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
134
131
113
118
126
134
135
157
191
182
189
215
226
Expenses
113
120
109
112
116
120
127
143
171
161
164
174
181
Operating Profit
21
11
4
5
9
14
8
15
20
21
25
41
46
OPM %
16%
8%
3.3%
4.6%
7%
11%
6%
9%
10%
12%
13%
19%
20%
Other Income
4
3
6
4
5
6
6
3
2
2
2
1
1
Interest
0
0
0
0
0
0
0
0
0
0
1
1
1
Depreciation
1
1
1
1
1
1
1
2
2
2
2
3
3
PBT
23
13
8
8
13
18
11
15
20
21
23
38
42
Tax %
34%
36%
27%
5%
24%
28%
26%
20%
23%
26%
24%
26%
Net Profit
16
8
6
8
10
13
8
12
15
15
17
28
32
EPS in Rs
25.62
13.7
10.1
13.29
16.63
21.29
13.98
20.4
25.26
25.34
28.45
47.01
52.32
Div. Payout %
14%
29%
40%
30%
60%
47%
72%
49%
396%
39%
35%
21%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
6
6
6
6
6
6
6
6
6
6
6
6
Reserves
98
103
112
118
125
130
133
139
88
103
113
135
Borrowings
1
2
0
0
2
0
0
0
0
0
13
8
Other Liabilities
15
17
21
16
22
24
26
25
23
25
27
26
Total Liabilities
120
128
140
140
155
161
165
170
117
134
159
175
Fixed Assets
23
23
22
25
24
26
29
27
28
27
33
41
CWIP
0
0
0
0
1
2
0
0
0
0
7
6
Investments
27
34
45
53
68
65
50
48
4
10
41
41
Other Assets
70
72
73
62
61
69
85
94
85
97
78
87
Total Assets
120
128
140
140
155
161
165
170
117
134
159
175
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
6
7
7
9
12
5
3
2
14
15
17
25
Investing
0
-7
-2
-2
-5
-4
6
10
44
-12
-29
-13
Financing
-3
-2
-5
-3
-1
-9
-7
-6
-67
0
5
-12
Net Cash Flow
3
-2
0
4
6
-8
2
6
-9
2
-6
0
Free Cash Flow
6
6
7
4
11
1
0
2
12
13
2
15
CFO/OP
66
99
246
208
152
58
96
42
101
90
92
79
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
41
47
52
59
56
55
48
36
37
44
48
49
Inventory Days
194
169
192
144
144
166
166
185
152
161
155
156
Days Payable
21
23
52
40
62
63
62
57
42
50
57
39
Cash Conversion Cycle
214
193
193
163
138
158
152
164
147
155
146
166
Working Capital Days
117
120
146
127
95
108
115
119
97
103
88
97
ROCE %
21%
12%
4%
5%
7%
11%
5%
10%
16%
20%
20%
28%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Narmada Gelatines insights

29 extracted metrics + investor summaries across FY15–FY26.

Log in — free

Shareholding Pattern

DIIs0.01%Promot.75.00%Others3.11%Public21.88%As ofJun 2026

Documents

Frequently Asked Questions about Narmada Gelatines

What does Narmada Gelatines Ltd do?
Incorporated in 1969, Narmada Gelatines Ltd manufactures and sells Gelatine and Ossein[1]
Where is Narmada Gelatines Ltd (526739) listed?
Narmada Gelatines Ltd trades as NARMADAGELATINESLTD on the NSE and under code 526739 on the BSE.
Which sector does Narmada Gelatines Ltd belong to?
Narmada Gelatines Ltd is classified under the Chemicals sector, in the Specialty Chemicals industry.
What is the market capitalisation of Narmada Gelatines Ltd?
Narmada Gelatines Ltd has a market capitalisation of ₹282.52 Cr, which places it in the Small Cap band.
What is the PE ratio of Narmada Gelatines Ltd?
Narmada Gelatines Ltd trades at a PE ratio of 8.20, on earnings per share of ₹23.8, against a book value of ₹240.09 per share.
What is the 52-week high and low of Narmada Gelatines Ltd?
Over the last 52 weeks Narmada Gelatines Ltd has traded between ₹327.3 and ₹545.
Does Narmada Gelatines Ltd pay dividends?
Narmada Gelatines Ltd has a dividend yield of 2.32%.
What is the Return on Equity (ROE) of Narmada Gelatines Ltd?
Narmada Gelatines Ltd reported a return on equity of 21.68%. Its debt-to-equity ratio is 0.06.

Company Information

Incorporated in 1969, Narmada Gelatines Ltd manufactures and sells Gelatine and Ossein[1]

CEO Mr. Ashok Kumar Kapur B.E.
Employees 198
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/526739.md for Narmada Gelatines Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More